Search Orphan Drug Designations and Approvals
-
| Generic Name: | tecarfarin |
|---|---|
| Date Designated: | 04/08/2024 |
| Orphan Designation: | Prevention of thromboembolism and thrombosis in patients with an implanted mechanical circulatory support device (left ventricular assist device, right ventricular assist device, biventricular assist device, total artificial heart) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Cadrenal Therapeutics 822 North A1A Ponte Vedra, Florida 32082 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







